Preclinical Differentiation between Apparently Safe and Potentially Hepatotoxic Applications of TRAIL Either Alone or in Combination with Chemotherapeutic Drugs

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) exhibits potent antitumor activity on systemic administration in nonhuman primates without deleterious side effects for normal tissue. However, there is a controversy about the potential toxicity of TRAIL on human hepatocytes. The...

Full description

Saved in:
Bibliographic Details
Main Authors: Tom M. Ganten, Ronald Koschny, Jaromir Sykora, Henning Schulze‐Bergkamen, Peter Büchler, Tobias L. Haas, Manuela B. Schader, Andreas Untergasser, Wolfgang Stremmel, Henning Walczak
Format: Artigo
Language:English
Published: 2006
Online Access:https://doi.org/10.1158/1078-0432.ccr-05-2635
https://aacrjournals.org/clincancerres/article-pdf/12/8/2640/1968793/2640.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!